Please login to the form below

Not currently logged in
Email:
Password:

Truxima

This page shows the latest Truxima news and features for those working in and with pharma, biotech and healthcare.

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

Mundipharma adds breast cancer biosimilar to its portfolio with Celltrion deal

This will be the third biosimilar Mundipharma and Celltrion has launched in the EU, following Remsima (infliximab) and Truxima (rituximab), biosimilars of Johnson and Johnson’s Remicade and Roche’s MabThera. ... With Remsima, we achieved market

Latest news

  • Roche faces biosimilar blitz in 2018 Roche faces biosimilar blitz in 2018

    Novartis’unit Sandoz and Celltrion/Mundipharma’s Truxima have also claimed a European approval for its biosimilar versions of Roche’s immunotherapy drug MabThera (rituximab).

  • Roche faces prospect of second Rituxan biosimilar in US Roche faces prospect of second Rituxan biosimilar in US

    It was the second biosimilar of Roche's drug to be approved in Europe after Celltrion/Mundipharma's Truxima, which also pipped Sandoz to the filing post in the US after

  • Standing out in a crowd Standing out in a crowd

    It followed that this year by gaining approval from the European Commission for the world’s first monoclonal antibody biosimilar of MabTera (rituximab), marketed as Truxima.

  • Sandoz joins Europe's MabThera biosimilar push Sandoz joins Europe's MabThera biosimilar push

    The approval - which comes four months after Celltrion/Mundipharma's Truxima biosimilar was cleared for marketing by the EMA - is for the entire range of indications awarded to MabThera, including ... Truxima claimed the distinction of being the first

  • WHO pilots scheme to make biosimilars available to poorer countries WHO pilots scheme to make biosimilars available to poorer countries

    Earlier this year the EMA approved Celltrion/Mundipharma's Truxima version of Rituxan, while other biosimilar copies of the drug have started to roll out in India, Latin America, and Russia,

More from news
Approximately 1 fully matching, plus 6 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Digitas Health

Digitas Health is the only digital-at-the-core brand agency designed to connect today's healthcare brands with today's healthcare consumers and professionals....

Latest intelligence

Developing advocacy in the pharmaceutical industry.
The importance of advocacy programmes...
GDPR and events. What does the pharma industry need to know?
Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
Digital trends in B2B sales - how far behind is Pharma?
The modern approach to B2B sales is data-driven, and enabled by digital tools....

Infographics